Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0714
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lipoprotein(a)-hyperlipoproteinemia as cause of chronic spinal cord ischemia resulting in progressive myelopathy – successful treatment with lipoprotein apheresis ; day:3 ; month:2 ; year:2017 ; pages:1-5
Clinical research in cardiology supplements ; (3.2.2017), 1-5
- Schlagwort
-
Kardiovaskuläre Krankheit
- Urheber
-
Heigl, Franz
- Beteiligte Personen und Organisationen
-
Hettich, Reinhard
Mauch, Erich
Klingel, Reinhard
Fassbender, Cordula
SpringerLink (Online service)
- DOI
-
10.1007/s11789-017-0081-4
- URN
-
urn:nbn:de:1111-2017030413233
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Heigl, Franz
- Hettich, Reinhard
- Mauch, Erich
- Klingel, Reinhard
- Fassbender, Cordula
- SpringerLink (Online service)
Ähnliche Objekte (12)
Current Role of Lipoprotein Apheresis
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
The development of lipoprotein apheresis in Saxony in the last years
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment
Current Role of Lipoprotein Apheresis
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
The development of lipoprotein apheresis in Saxony in the last years
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results
Detailed description of the cardiovascular situation in patients who have started lipoprotein apheresis treatment
Current Role of Lipoprotein Apheresis
Lipoprotein apheresis affects the concentration of extracellular vesicles in patients with elevated lipoprotein (a)
Lipoprotein glomerulopathy treated with LDL-apheresis (Heparin-induced Extracorporeal Lipoprotein Precipitation system): a case report
Factors inducing cardiovascular events in patients treated by lipoprotein apheresis
The German Lipoprotein Apheresis Registry (GLAR) – almost 5 years on
Aktuelle Situation der Lipoprotein-Apherese in Sachsen 2013 : = Actual situation of lipoprotein apheresis in Saxony in 2013
The development of lipoprotein apheresis in Saxony in the last years
Repeated lipoprotein apheresis and immune response : Effects on different immune cell populations
Use of CMR imaging to assess the effect of lipoprotein apheresis in patients with refractory angina and raised lipoprotein(a)
Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels
Lipoprotein(a) apheresis in patients with peripheral arterial disease: rationale and clinical results